MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin

Didier Hocquet et al. Antimicrob Agents Chemother. 2007 Apr.

. 2007 Apr;51(4):1582-3.

doi: 10.1128/AAC.01334-06. Epub 2007 Jan 12.

No abstract available

References

1. Dumas, J. L., C. Delden, K. Perron, and T. Köhler. 2006. Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR. FEMS Microbiol. Lett. 254:217-225. - PubMed
1. Hocquet, D., P. Nordmann, F. El Garch, L. Cabanne, and P. Plésiat. 2006. Involvement of the efflux system MexXY-OprM in the emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 50:1347-1351. - PMC - PubMed
1. Llanes, C., D. Hocquet, C. Vogne, D. Bénali-Baitich, C. Neuwirth, and P. Plésiat. 2004. Clinical strains of Pseudomonas aeruginosa overproducing simultaneously MexAB-OprM and MexXY efflux pumps. Antimicrob. Agents Chemother. 48:1797-1802. - PMC - PubMed
1. Lomovskaya, O., M. S. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V. J. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116. - PMC - PubMed
1. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 6th ed. M7, A6. National Committee for Clinical Laboratory Standards, Wayne, PA.